Precigen (PGEN) Acquisitions (2013 - 2018)

Precigen (PGEN) reported Acquisitions of $920000.0 for Q4 2018, down 90.26% quarter-over-quarter from $9.4 million in Q4 2015.

Precigen (PGEN) Acquisitions (2013 - 2018) Analysis & Trends

Precigen (PGEN) has 4 years of Acquisitions data on file, last reported at $920000.0 in Q4 2018.

Acquisitions for Q4 2018 came in at $920000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $920000.0 (changed N/A YoY), and the FY2018 annual result was $920000.0, up 144.79% from the prior year.
Acquisitions eased to $920000.0 in Q4 2018 per PGEN's latest filing, from $9.4 million in the prior quarter.
Over five years, Acquisitions peaked at $75.0 million in Q3 2015 and troughed at $460000.0 in Q4 2014.
A 3-year average of $24.1 million and a median of $9.7 million in 2015 frame the typical range for Acquisitions.
The sharpest annual moves came in 2014 and 2015: Acquisitions surged 9300.0% in 2014, then climbed 20.54% in 2015.
A 3-year view of Acquisitions shows it stood at $460000.0 in 2014, then soared by 1953.91% to $9.4 million in 2015, then slumped by 90.26% to $920000.0 in 2018.
Business Quant data shows PGEN's Acquisitions at $920000.0 in Q4 2018, $9.4 million in Q4 2015, and $75.0 million in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Precigen	1.27 Bn	1.27 Bn	20.69 Mn	-

Download Data